A critical advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This essential tumor suppressor protein is frequently inactivated in various kinds of malignancies, leading https://bookmarkboom.com/story21908803/mini-antibodies-restore-p53-a-promising-pathway-for-malignant-management